BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23240172)

  • 21. Disease transmission: routes, contributing factors and herd immunity.
    O'Brien K
    Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991.
    Loughlin AM; Marchant CD; Lett SM
    Am J Public Health; 1995 Mar; 85(3):392-4. PubMed ID: 7892925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
    Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G
    Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meningococcal vaccine for infants.
    Med Lett Drugs Ther; 2013 Nov; 55(1429):92. PubMed ID: 24220580
    [No Abstract]   [Full Text] [Related]  

  • 31. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
    Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
    Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active offer of vaccinations during hospitalization improves coverage among splenectomized patients: An Italian experience.
    Gallone MS; Martino C; Quarto M; Tafuri S;
    Am J Infect Control; 2017 Aug; 45(8):e87-e89. PubMed ID: 28410825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance.
    Giufrè M; Cardines R; Caporali MG; Accogli M; D'Ancona F; Cerquetti M
    Vaccine; 2011 May; 29(22):3857-62. PubMed ID: 21459175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination update. Hib, hepatitis, polio, varicella, influenza, pneumococcal and meningococcal disease.
    Vetter RT; Johnson GM
    Postgrad Med; 1995 Nov; 98(5):141-4, 146, 149-50. PubMed ID: 7479450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perioperative management of asplenic patients].
    Legrand A; Bignon A; Borel M; Zerbib P; Langlois J; Chambon JP; Lebuffe G; Vallet B
    Ann Fr Anesth Reanim; 2005 Jul; 24(7):807-13. PubMed ID: 15967628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs.
    Hausdorff WP; Hajjeh R; Al-Mazrou A; Shibl A; Soriano-Gabarro M;
    Vaccine; 2007 Mar; 25(11):1935-44. PubMed ID: 17241707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.